1. Home
  2. MP vs RGEN Comparison

MP vs RGEN Comparison

Compare MP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MP Materials Corp.

MP

MP Materials Corp.

HOLD

Current Price

$56.13

Market Cap

7.4B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$176.26

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MP
RGEN
Founded
2017
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.6B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
MP
RGEN
Price
$56.13
$176.26
Analyst Decision
Strong Buy
Buy
Analyst Count
13
12
Target Price
$75.25
$167.67
AVG Volume (30 Days)
6.8M
971.2K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
12.28
286.96
EPS
N/A
0.24
Revenue
$331,952,000.00
$141,236,000.00
Revenue This Year
$100.51
$14.30
Revenue Next Year
$60.41
$14.52
P/E Ratio
N/A
$758.46
Revenue Growth
147.15
35.10
52 Week Low
$37.81
$100.99
52 Week High
$100.25
$188.73

Technical Indicators

Market Signals
Indicator
MP
RGEN
Relative Strength Index (RSI) 53.93 66.61
Support Level $56.20 $156.65
Resistance Level $57.46 $188.73
Average True Range (ATR) 3.38 6.21
MACD 0.26 0.29
Stochastic Oscillator 38.61 62.11

Price Performance

Historical Comparison
MP
RGEN

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: